Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Heart, Lung & Circulation
|
June 5, 2012
Cell therapy for left ventricular dysfunction: an overview for cardiac clinicians
James J H Chong
Heart, Lung & Circulation
|
July 5, 2023
Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond
Tejas Deshmukh, James J H Chong
Expert Review of Cardiovascular Therapy
|
July 1, 2004
Heparin-induced thrombocytopenia
Beng H Chong, James J H Chong
Blood
|
July 13, 2013
HIT: nucleic acid masquerading as heparin
Beng H Chong, James J-H Chong
Biophysical Reviews
|
July 22, 2020
Growth factor therapy for cardiac repair: an overview of recent advances and future directions
Samuel J White, James J H Chong
Clinical Therapeutics
|
September 17, 2020
Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and Fibroblasts
Samuel J White, James J H Chong
Clinical Therapeutics
|
October 4, 2020
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular Therapies
Robert D Hume, James J H Chong
Stem Cell Research
|
August 5, 2014
Cardiac regeneration using pluripotent stem cells--progression to large animal models
James J H Chong, Charles E Murry
Current Cardiology Reports
|
March 11, 2022
Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
Dinesh Selvakumar, Leila Reyes, James J H Chong
Heart, Lung & Circulation
|
June 6, 2016
Therapeutic Prospects of Gene Therapy for Atrial Fibrillation
Melad Farraha, James J H Chong, Eddy Kizana
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Heart, Lung & Circulation
|
June 5, 2012
Cell therapy for left ventricular dysfunction: an overview for cardiac clinicians
James J H Chong
Heart, Lung & Circulation
|
July 5, 2023
Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond
Tejas Deshmukh, James J H Chong
Expert Review of Cardiovascular Therapy
|
July 1, 2004
Heparin-induced thrombocytopenia
Beng H Chong, James J H Chong
Blood
|
July 13, 2013
HIT: nucleic acid masquerading as heparin
Beng H Chong, James J-H Chong
Biophysical Reviews
|
July 22, 2020
Growth factor therapy for cardiac repair: an overview of recent advances and future directions
Samuel J White, James J H Chong
Clinical Therapeutics
|
September 17, 2020
Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and Fibroblasts
Samuel J White, James J H Chong
Clinical Therapeutics
|
October 4, 2020
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular Therapies
Robert D Hume, James J H Chong
Stem Cell Research
|
August 5, 2014
Cardiac regeneration using pluripotent stem cells--progression to large animal models
James J H Chong, Charles E Murry
Current Cardiology Reports
|
March 11, 2022
Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
Dinesh Selvakumar, Leila Reyes, James J H Chong
Heart, Lung & Circulation
|
June 6, 2016
Therapeutic Prospects of Gene Therapy for Atrial Fibrillation
Melad Farraha, James J H Chong, Eddy Kizana
Page
of 7